Back to top
more

Phreesia (PHR)

(Delayed Data from NYSE)

$21.96 USD

21.96
290,280

+0.02 (0.09%)

Updated May 9, 2024 04:00 PM ET

After-Market: $21.94 -0.02 (-0.09%) 5:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 250)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Wall Street Analysts See a 38% Upside in Phreesia (PHR): Can the Stock Really Move This High?

The mean of analysts' price targets for Phreesia (PHR) points to a 37.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Here's Why Phreesia (PHR) Is a Great 'Buy the Bottom' Stock Now

After losing some value lately, a hammer chart pattern has been formed for Phreesia (PHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Wall Street Analysts Think Phreesia (PHR) Could Surge 26%: Read This Before Placing a Bet

The consensus price target hints at a 25.5% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 9.17% and 1.49%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

Phreesia (PHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Phreesia (PHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nextgen Healthcare (NXGN) Q4 Earnings Miss Estimates

Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of -5% and 0.24%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Phreesia (PHR) Surges 7%: Is This an Indication of Further Gains?

Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Privia Health (PRVA) Tops Q1 Earnings and Revenue Estimates

Privia Health (PRVA) delivered earnings and revenue surprises of 500% and 5.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Strata Skin Sciences, Inc. (SSKN) Reports Q1 Loss, Tops Revenue Estimates

Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -40% and 1.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CareCloud, Inc. (MTBC) Reports Q1 Loss, Tops Revenue Estimates

CareCloud, Inc. (MTBC) delivered earnings and revenue surprises of 29.63% and 5.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 14.29% and 3.93%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Misses Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0% and 27.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Phreesia (PHR) Soars 5.9%: Is Further Upside Left in the Stock?

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Health Catalyst (HCAT) Reports Q4 Loss, Tops Revenue Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of 9.52% and 2.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Company News for Dec 10, 2021

Companies in The News Are: GME,GEF,PHR,NAPA

Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of -51.06% and 15.19%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for December 6th

BYND, NVST, FSTR, ZBH, and PHR have been added to the Zacks Rank #5 (Strong Sell) List on December 6, 2021.

Earnings Preview: Phreesia (PHR) Q3 Earnings Expected to Decline

Phreesia (PHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for November 29th

DVA, NVST, WWD, PHR, and ROAD have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2021

Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of -118.18% and 8.71%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Phreesia (PHR) Q2 Earnings Expected to Decline

Phreesia (PHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for July 6th

DXCM, GP, PHR, RAD, and MAXR have been added to the Zacks Rank #5 (Strong Sell) List on July 6, 2021

Phreesia (PHR) is Overbought: Is A Drop Coming?

Phreesia (PHR) has moved higher as of late, but there could definitely be trouble on the horizon for this company

Analysts Estimate Phreesia (PHR) to Report a Decline in Earnings: What to Look Out for

Phreesia (PHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of -20.00% and 5.74%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?